文献速递传染病防控与疫情报告免疫规划

英格兰伦敦养老院部分接种单剂Vaxzevria后暴发SARS-CoV-2 Delta变异株疫情

An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021.
PubMed 文献 · Euro Surveill · 2021-01-01

2021年4月伦敦一家养老院发生SARS-CoV-2 Delta变异株暴发,21名住户中8人、21名员工中14人已接种单剂Vaxzevria。40人中检出24例感染(16名住户、8名员工),4人住院(3名住户、1名员工),无死亡。单剂疫苗后罹患率员工为35.7%(5/14),住户为81.3%(13/16)。

要点

  • 单剂Vaxzevria接种后养老院仍发生Delta变异株暴发,住户罹患率高于员工。
  • 暴发共24例感染,4人住院,无死亡。
  • 部分接种后需持续感染防控,尤其养老院住户。

核心结论

  • 在部分接种单剂Vaxzevria的养老院中仍发生SARS-CoV-2 Delta变异株暴发,住户罹患率高于员工。

研究设计与样本

  • 对伦敦一家养老院COVID-19暴发开展调查,该院21名住户中8人、21名员工中14人已接种单剂Vaxzevria。

主要发现

  • 40人中检出24例SARS-CoV-2感染(16名住户、8名员工)。
  • 4人住院(3名住户、1名员工),无死亡。
  • 单剂疫苗后罹患率员工为35.7%(5/14),住户为81.3%(13/16)。

临床怎么用

  • 养老院在部分接种疫苗后仍需加强感染防控与监测,尤其关注住户。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated a COVID-19 outbreak of the SARS-CoV-2 Delta variant of concern in a London care home, where 8/21 residents and 14/21 staff had received a single dose of Vaxzevria (ChAdOx1-S; AstraZeneca) vaccine. We identified 24 SARS-CoV-2 infections (16 residents, 8 staff) among 40 individuals (19 residents, 21 staff); four (3 residents, 1 staff) were hospitalised, and none died. The attack rate after one vaccine dose was 35.7% (5/14) for staff and 81.3% (13/16) for residents.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Williams SV, Vusirikala A, Ladhani SN, et al. An outbreak caused by the SARS-CoV-2 Delta (B.1.617.2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021. Euro Surveill. 2021. PMID: 34240699. doi:10.2807/1560-7917.ES.2021.26.27.2100626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。